Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Harnessing CRISPR-Cas9 for genome editing in Streptococcus pneumoniae

View ORCID ProfileDimitra Synefiaridou, View ORCID ProfileJan-Willem Veening
doi: https://doi.org/10.1101/2020.06.13.149682
Dimitra Synefiaridou
Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dimitra Synefiaridou
Jan-Willem Veening
Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan-Willem Veening
  • For correspondence: Jan-Willem.Veening@unil.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

CRISPR systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by detection and cleavage of invading foreign DNA. Modified versions of this system can be exploited as a biotechnological tool for precise genome editing at a targeted locus. Here, we developed a novel, replicative plasmid that carries the CRISPR-Cas9 system for RNA-programmable, genome editing by counterselection in the opportunistic human pathogen Streptococcus pneumoniae. Specifically, we demonstrate an approach for making targeted, marker-less gene knockouts and large genome deletions. After a precise double-stranded break (DSB) is introduced, the cells’ DNA repair mechanism of homology-directed repair (HDR) pathway is being exploited to select successful transformants. This is achieved through the transformation of a template DNA fragment that will recombine in the genome and eliminate recognition of the target of the Cas9 endonuclease. Next, the newly engineered strain, can be easily cured from the plasmid that is temperature-sensitive for replication, by growing it at the non-permissive temperature. This allows for consecutive rounds of genome editing. Using this system, we engineered a strain with three major virulence factors deleted. The here developed approaches should be readily transportable to other Gram-positive bacteria.

Importance Streptococcus pneumoniae (the pneumococcus) is an important opportunistic human pathogen killing over a million people each year. Having the availability of a system capable of easy genome editing would significantly facilitate drug discovery and vaccine candidate efforts. Here, we introduced an easy to use system to perform multiple rounds of genome editing in the pneumococcus by putting the CRISPR-Cas9 system on a temperature-sensitive replicative plasmid. The here used approaches will advance genome editing projects in this important human pathogen.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Inclusion of a reference to Jiang et al. 2013 that was accidentally omitted from the first submitted version.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 14, 2020.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Harnessing CRISPR-Cas9 for genome editing in Streptococcus pneumoniae
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Harnessing CRISPR-Cas9 for genome editing in Streptococcus pneumoniae
Dimitra Synefiaridou, Jan-Willem Veening
bioRxiv 2020.06.13.149682; doi: https://doi.org/10.1101/2020.06.13.149682
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Harnessing CRISPR-Cas9 for genome editing in Streptococcus pneumoniae
Dimitra Synefiaridou, Jan-Willem Veening
bioRxiv 2020.06.13.149682; doi: https://doi.org/10.1101/2020.06.13.149682

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3686)
  • Biochemistry (7780)
  • Bioengineering (5672)
  • Bioinformatics (21252)
  • Biophysics (10565)
  • Cancer Biology (8164)
  • Cell Biology (11916)
  • Clinical Trials (138)
  • Developmental Biology (6744)
  • Ecology (10390)
  • Epidemiology (2065)
  • Evolutionary Biology (13846)
  • Genetics (9698)
  • Genomics (13058)
  • Immunology (8131)
  • Microbiology (19973)
  • Molecular Biology (7839)
  • Neuroscience (42996)
  • Paleontology (318)
  • Pathology (1276)
  • Pharmacology and Toxicology (2257)
  • Physiology (3350)
  • Plant Biology (7215)
  • Scientific Communication and Education (1309)
  • Synthetic Biology (2000)
  • Systems Biology (5529)
  • Zoology (1126)